Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial
- DOI
- 10.1136/openhrt-2026-004312
- Published
- 2026-07
- Container
- Open Heart
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/openhrt-2026-004312,
title = {Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial},
author = {Jose L. Batista and Yuxi Liu and Javed Butler and Stefano Del Prato and Justin A Ezekowitz and Carolyn S P Lam and Thomas H Marwick and Julio Rosenstock and W H Wilson Tang and Riccardo Perfetti and Alessia Urbinati and Faiez Zannad and Onyedika Ilonze and James L Januzzi},
year = {2026},
journal = {Open Heart},
doi = {10.1136/openhrt-2026-004312},
url = {https://doi.org/10.1136/openhrt-2026-004312}
}RIS
TY - JOUR TI - Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial AU - Jose L. Batista AU - Yuxi Liu AU - Javed Butler AU - Stefano Del Prato AU - Justin A Ezekowitz AU - Carolyn S P Lam AU - Thomas H Marwick AU - Julio Rosenstock AU - W H Wilson Tang AU - Riccardo Perfetti AU - Alessia Urbinati AU - Faiez Zannad AU - Onyedika Ilonze AU - James L Januzzi PY - 2026 JO - Open Heart DO - 10.1136/openhrt-2026-004312 UR - https://doi.org/10.1136/openhrt-2026-004312 ER -
APA
Batista, J. L., Liu, Y., Butler, J., Prato, S. D., Ezekowitz, J. A., Lam, C. S. P., Marwick, T. H., Rosenstock, J., Tang, W. H. W., Perfetti, R., Urbinati, A., Zannad, F., Ilonze, O., & Januzzi, J. L. (2026). Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial. Open Heart. https://doi.org/10.1136/openhrt-2026-004312
Source records
- crossref · retrieved 2026-11-10T16:29:43.709Z